The Oncology Institute, Inc. TOI Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s accrued expenses?
- The Oncology Institute, Inc. (TOI) reported accrued expenses of $5.8M in Q1 2026.
- How has The Oncology Institute, Inc.'s accrued expenses changed year-over-year?
- The Oncology Institute, Inc.'s accrued expenses decreased by 17.0% year-over-year, from $6.99M to $5.8M.
- What is the long-term trend for The Oncology Institute, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), The Oncology Institute, Inc.'s accrued expenses has grown at a -5.6% compound annual growth rate (CAGR), from $9.45M to $7.09M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.